Finding needles in haystacks: OMass unveils pipeline aimed at tough-to-drug targets
November 17, 2021
Is big pharma falling back in love with small molecules?
July 6, 2021
New approaches to small-molecule design allow difficult targets to be addressed, such as the G protein-coupled receptors (GPCR) on cell...
Women in Bio: OMass Taps Biogen Vet Nathalie Franchimont for Board of Directors
August 18, 2020
When U.K.-based OMass Therapeutics began the search for a new member for its board of directors, Chief Executive Officer Rosamond...